Stimulus Spending Cracks 40 Percent
The Obama administration has spent $317 billion of last February’s American Recovery and Reinvestment Act, according to the latest numbers from Recovery.gov. The funds include $198 billion in spending and an estimated $119 billion in tax cuts, and represent just over 40 percent of the nearly $800 billion stimulus package.
You can track stimulus spending by agency on our interactive Stimulus Progress Bar. You can also see how fast that money is moving out the door, by checking out our Stimulus Speed Chart.
This article is part of an ongoing investigation:
Officials have struggled to spend the nearly $800 billion stimulus package quickly and effectively.
Latest Stories in this Project
Get Updates
Our Hottest Stories
- The 182 Percent Loan: How Installment Lenders Put Borrowers in a World of Hurt
- IRS Office That Targeted Tea Party Also Disclosed Confidential Docs From Conservative Groups
- Medicare Drug Program Fails to Monitor Prescribers, Putting Seniors and Disabled at Risk
- On Victory Drive, Soldiers Defeated by Debt
- The Most Important #Muckreads on Rape in the Military
- Everything We Know About What’s Happened Under Sequestration
- The Story Behind Our Hospital Interactive
- Is Obama Delivering on His Promise of a “21st Century” Approach to Drugs?
- Lifting the Veil on Dangerous Prescribing
- FAQ: What You Need to Know About Prescriber Checkup
- IRS Office That Targeted Tea Party Also Disclosed Confidential Docs From Conservative Groups
- The 182 Percent Loan: How Installment Lenders Put Borrowers in a World of Hurt
- Everything We Know About What’s Happened Under Sequestration
- On Victory Drive, Soldiers Defeated by Debt
- Medicare Drug Program Fails to Monitor Prescribers, Putting Seniors and Disabled at Risk
- How the IRS’s Nonprofit Division Got So Dysfunctional
- Is Obama Delivering on His Promise of a “21st Century” Approach to Drugs?
- Intern vs. Mayor: Battle Bares Bloomberg's Argument for Secrecy
- The Most Important #Muckreads on Rape in the Military
- How We Analyzed Medicare’s Drug Data
